Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about BAG5: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
BAG5 (BCL2-associated athanogene 5) multi-domain co-chaperone, involved in Parkinson's disease, mitochondrial quality control, and alpha-synuclein aggregation
No AI portrait yet
| Gene Symbol | BAG5 |
| Full Name | BCL2-Associated Athanogene 5 |
| Chromosome | 14q32.33 |
| Protein Family | BAG family, Hsp70 co-chaperones |
| Protein Type | Chaperone |
| Function | is a multi-domain co-chaperone protein that plays critical roles in neuronal survival, protein quality control, mitochondrial dynamics, and autophagy regulation. |
| Primary Expression | vulnerable neuronal populations including dopaminergic neurons of the substantia nigra pars compacta, cortical neurons, hippocampal neurons, and cereb |
| Subcellular Localization | , including nuclear localization signals and mitochondrial targeting sequences. This enables BAG5 to function in multipl |
| Molecular Weight | 49 kDa |
| Amino Acids | 446 aa |
| Exons | 17 |
| UniProt ID | [Q9NS69](https://www.uniprot.org/uniprot/Q9NS69) |
| Ensembl ID | ENSG00000164478 |
| GeneCards | BAG5 |
| Human Protein Atlas | BAG5 |
| Associated Diseases | Parkinson's disease |
| Databases | GeneCardsNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
BAG5["BAG5"]
style BAG5 fill:#1a237e,stroke:#4fc3f7,stroke-width:3px,color:#fff
neurodegeneration["neurodegeneration"]
BAG5 -->|"implicated_in"| neurodegeneration
classDef gene fill:#1a3a2a,stroke:#4caf50,color:#e0e0e0
classDef protein fill:#1a2a3a,stroke:#4fc3f7,color:#e0e0e0
classDef disease fill:#3a1a1a,stroke:#ef5350,color:#e0e0e0
classDef pathway fill:#2a1a3a,stroke:#ce93d8,color:#e0e0e0
classDef mechanism fill:#2a2a1a,stroke:#ffd54f,color:#e0e0e0
classDef drug fill:#1a2a2a,stroke:#80cbc4,color:#e0e0e0
class neurodegeneration disease| Target | Relation | Type | Str |
|---|---|---|---|
| No outgoing edges | |||
| Source | Relation | Type | Str |
|---|---|---|---|
| No incoming edges | |||
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning BAG5 in their description or question text
No additional research found